Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Raffles Medical Group ( (SG:BSL) ) has provided an update.
Raffles Medical Group has strengthened its leadership team by appointing Dr. Kenneth Wu and Dr. Sarah Lu as Co-Managing Directors for its Singapore Healthcare division, alongside the introduction of Mr. Terence Foo as the new Chief Technology Officer. These strategic appointments are expected to enhance the operational and commercial management of the Group’s healthcare services in Singapore and Indochina, potentially improving service delivery and expanding its market presence.
The most recent analyst rating on (SG:BSL) stock is a Buy with a S$1.10 price target. To see the full list of analyst forecasts on Raffles Medical Group stock, see the SG:BSL Stock Forecast page.
More about Raffles Medical Group
Raffles Medical Group is a prominent player in the healthcare industry, offering a range of medical services through its hospitals and clinics. The company focuses on delivering comprehensive healthcare solutions in Singapore and Indochina, with a strong emphasis on both primary care and specialized medical services.
Average Trading Volume: 2,290,876
Technical Sentiment Signal: Buy
Current Market Cap: S$1.94B
For detailed information about BSL stock, go to TipRanks’ Stock Analysis page.